Skyscape Web Viewer : The Maudsley Prescribing Guidelines in Psychiatry : Main Index

View All
Clozapine/norclozapine ratio
Clozapine dose (in mg/day) with the highest likelihood of providing a plasma concentration of 350mcg/L, estimated by extrapolation of concentrations reported for different populations
clozapine-induced GI hypomotility (CIGH) 263-266 clozapine rechallenge following severe constipation prevention and simple management Acting on clozapine plasma concentration results management of suspected acute CIGH risk factors
Clozapine rechallenge following severe constipation
Clozapine
Cocaine
Cochrane review acute behavioural disturbance catatonia treatment smoking cessation benzodiazepines long-acting injectable antipsychotics
Cognitive behavioural therapy Bipolar disorder in children and adolescents Obsessive compulsive disorder (OCD) and body dysmorphic disorder (BDD) in children and adolescents Depression in children and adolescents Post-traumatic stress disorder (PTSD) in children and adolescents
cognitive behavioural therapy (CBT) anxiety spectrum disorders children and adolescents benzodiazepine withdrawal psychosis
Cognitive decline, anticholinergic drugs
Collaboration enhancing medication adherence importance to outcomes Working towards adherence prescribing influences
Combination treatment
combined oral contraceptive pill (COCP), premenstrual syndrome
Commonly used treatments, generally well supported by published literature (no preference implied by order)
Communication, patient factor in prescribing
Community detoxification, alcohol withdrawal
Community initiation dosing initial work-up mandatory blood monitoring and registration relative contraindications switching from other antipsychotics adverse effects essential criteria for Initiation of clozapine in the community recommended additional monitoring serious cardiac adverse effects titration schedules
Community Treatment Order (CTO), Mental Health Act
Comorbid with eating disorders
Constipation, clozapine-induced Acting on clozapine plasma concentration results Clozapine-induced gastrointestinal hypomotility
Constipation causing drugs, avoid in hepatic impairment
Conventional sublingual buprenorphine daily treatment doses and recommended corresponding doses of weekly and monthly Buvidal
co-prescribed with warfarin leading to non-GI bleeding risk
Countertherapeutic use of medication
Covert administration of medicines in food and drink, older people Covert administration of medicines within food and drink General principles in prescribing in older adults
COVID-19
C-reactive protein in blood, psychotropic agent effects
creatine kinase (CK) elevations, antiretrovirals
Creatinine in blood, psychotropic agent effects
Cross-tapering, switching